Tesla, led by Elon Musk, is predicted to reach a $5 trillion valuation in the next decade, driven by technological advancements. Autonomous driving is central to Tesla’s strategy, with its Full Self-Driving (FSD) feature paving the way for a future of self-driving

Eric Schwartz joins Quantum Computing Inc. (QCi), bolstering its board with his extensive financial expertise. QCi is at the forefront of integrated photonics, poised to revolutionize AI and cybersecurity with room-temperature quantum machines. Schwartz brings two decades of experience in corporate finance,

Microsoft withdraws from over 2 gigawatts of data center leases in the U.S. and Europe, reshaping its strategy and realigning infrastructural goals. The company shifts focus from supporting OpenAI’s training workloads to sustaining cloud and inference workloads. Google and Meta capitalize on

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers with high recurrence and limited treatment options. Scientists Yana Zavros and Tad George explore PDAC using spatial biology and patient-derived organoids (PDOs) to understand the tumor microenvironment (TME). They map cellular interactions

Broadcom is advancing AI and machine learning through new cutting-edge DSP products, signaling a major strategic push in AI infrastructure. Despite market fluctuations, Broadcom’s shares remain steady amidst technology sector declines. Broadcom’s total return over the past five years has been an

The fusion of quantum computing and artificial intelligence holds transformative potential, promising advancements across industries like healthcare and finance. Oxford researchers, led by Professor David Lucas, are advancing quantum interconnectivity by linking multiple quantum processors, which enhances scalability and development of quantum

AI and quantum computing are intertwining, driven by IBM, Alphabet, and Nvidia to reshape technology’s frontier. Nvidia leads in AI with developments like ChatGPT, with its sales surging by nearly 400%, setting the stage for further quantum advancements. Alphabet’s AI innovations, including

Prostate cancer treatment is undergoing a transformative shift toward precision medicine. Current research focuses on understanding the genetic makeup of prostate tumors to personalize therapies. Targeted therapies like capivasertib show promise in delaying disease progression for PTEN-deficient metastatic prostate cancer. Innovative clinical

IBM has transformed into a leader in enterprise AI, focusing on business solutions with Watsonx, an AI model designed for complex data handling and security. Unlike its consumer-facing rivals, IBM’s strategy centers on enterprise consulting, translating to rapid growth in Watsonx contracts